In addition to Macquarie, Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh also received a Buy from Morgans’s Derek Jellinek in a report issued yesterday. However, on the same day, Morgan Stanley maintained a Hold rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (ASX: RMD).
Based on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of A$1.42 billion and a net profit of A$395.1 million. In comparison, last year the company earned a revenue of A$1.29 billion and had a net profit of A$365.04 million
